$STXS News

Piper Sandler Reiterates Overweight on Stereotaxis, Lowers Price Target to $3.5

Stereotaxis, Inc. (STXS) Q1 2026 Earnings Call Transcript

Stereotaxis Inc (NYSEARCA:STXS) Slides 6% After Q1 Revenue Miss Despite Narrower-Than-Expected Loss

Stereotaxis Q1 2026 Earnings Call Transcript

Stereotaxis Q1 EPS $(0.06) Misses $(0.05) Estimate, Sales $6.291M Miss $8.620M Estimate

Stereotaxis, Inc. (STXS) M&A Call Transcript

Stereotaxis Eyes Billions In Market Opportunity With Robocath Takeover

Stereotaxis To Acquire Robocath, A Venture-Backed Producer Of Robotic Technologies For Interventional Cardiology And Neurointerventions; Terms Not Disclosed

Stereotaxis Receives FDA 510(k) Clearance For Synchrony System

STX Semiconductor Co. Files Prospectus To Offer Up To $100M In Debt, Equity, Warrants, Rights, And Units

Stereotaxis: Medical Robotics Upside Offsets Cash Burn And Execution Risks

STEREOTAXIS INC (NYSEARCA:STXS) Posts Narrower-Than-Expected Q4 Loss Despite Revenue Miss

Stereotaxis, Inc. (STXS) Q4 2025 Earnings Call Transcript

Stereotaxis Q4 Earnings Summary & Key Takeaways

Stereotaxis Q4 EPS $(0.06), Inline, Sales $8.642M Miss $9.080M Estimate

Preview: Stereotaxis's Earnings

Stereotaxis Launches New Robotic Electrophysiology Program At Klinikum Fürth In Fürth, Germany

Stereotaxis Launches New Robotic Electrophysiology Program At Klinikum Fürth In Fürth, Germany

Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter

Stereotaxis shares are trading higher after the company announced it received FDA approval for its MAGiC Magnetic Interventional Ablation Catheter.